• 8190 Citations
  • 27 Scopus h-Index
20022019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2002 2019

Filter
Review article
1 Citation (Scopus)

Adjuvant Antiangiogenic Agents in Post-nephrectomy Renal Cell Carcinoma: A Systematic Review and Meta-analysis

Sonbol, M. B., Firwana, B., Hilal, T., Wang, Z., Almader-Douglas, D., Joseph, R. W. & Ho, T. H., Jun 1 2018, In : European Urology Oncology. 1, 2, p. 101-108 8 p.

Research output: Contribution to journalReview article

Angiogenesis Inhibitors
Nephrectomy
Renal Cell Carcinoma
Meta-Analysis
Disease-Free Survival
10 Citations (Scopus)

Cutaneous melanoma, version 2.2019

Coit, D. G., Thompson, J. A., Albertini, M. R., Barker, C., Carson, W. E., Contreras, C., Daniels, G. A., DiMaio, D., Fields, R. C., Fleming, M. D., Freeman, M., Galan, A., Gastman, B., Guild, V., Johnson, D., Joseph, R. W., Lange, J. R., Nath, S., Olszanski, A. J., Ott, P. & 10 others, Gupta, A. P., Ross, M. I., Salama, A. K., Skitzki, J., Sosman, J., Swetter, S. M., Tanabe, K. K., Wuthrick, E., McMillian, N. R. & Engh, A. M., Apr 1 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 4, p. 367-402 36 p.

Research output: Contribution to journalReview article

Open Access
Melanoma
Skin
Practice Guidelines
Therapeutics
Guidelines
7 Citations (Scopus)

Nivolumab treatment for advanced renal cell carcinoma: Considerations for clinical practice

Joseph, R. W., Chatta, G. & Vaishampayan, U., Apr 1 2017, In : Urologic Oncology: Seminars and Original Investigations. 35, 4, p. 142-148 7 p.

Research output: Contribution to journalReview article

Renal Cell Carcinoma
Sirolimus
Immunotherapy
Vascular Endothelial Growth Factor A
Antibody Formation
5 Citations (Scopus)

Patient-derived tumor xenograft models for melanoma drug discovery

Harris, A. L., Joseph, R. W. & Copland, J. A. III., Sep 1 2016, In : Expert Opinion on Drug Discovery. 11, 9, p. 895-906 12 p.

Research output: Contribution to journalReview article

Drug Discovery
Heterografts
Melanoma
Neoplasms
Skin
9 Citations (Scopus)

Prolonged benefit from ipilimumab correlates with improved outcomes from subsequent pembrolizumab

Shreders, A., Joseph, R. W., Peng, C., Ye, F., Zhao, S., Puzanov, I., Sosman, J. A. & Johnson, D. B., Jul 1 2016, In : Cancer immunology research. 4, 7, p. 569-573 5 p.

Research output: Contribution to journalReview article

Disease-Free Survival
Melanoma
Logistic Models
pembrolizumab
ipilimumab